Acute intermittent morphine increases preprodynorphin and kappa opioid receptor mRNA levels in the rat brain

Area of Science:

• Neuroscience
• Pharmacology
• Molecular Biology

Background:

• Opioid analgesics like morphine are widely used.
• The endogenous opioid system, including dynorphin and enkephalin pathways, modulates pain and other CNS functions.
• Understanding how morphine affects opioid peptide and receptor gene expression is crucial for elucidating its mechanisms of action and potential side effects.

Purpose of the Study:

• To investigate the impact of chronic morphine administration on the mRNA expression of opioid ligands preprodynorphin (PPD) and preproenkephalin (PPE).
• To examine the effect of morphine on the mRNA levels of the kappa opioid receptor (KOR).
• To explore the potential role of the kappa/dynorphin system in mediating or counteracting morphine's central effects.

Main Methods:

• Rats were administered multiple injections of morphine sulfate (6.25 mg/kg/injection) at 2-hour intervals.
• Brain tissue, excluding the cortex, cerebellum, and brainstem, was collected 30 minutes after the final injection.
• Quantitative analysis of mRNA levels for PPD, PPE, and KOR was performed using established molecular biology techniques.

Main Results:

• Morphine treatment led to a significant increase in mRNA levels for preprodynorphin (PPD) (P<0.05).
• A significant elevation in kappa opioid receptor (KOR) mRNA levels was observed (P<0.005).
• No significant alterations were found in the mRNA levels of preproenkephalin (PPE).

Conclusions:

• Chronic morphine administration upregulates the expression of dynorphin (PPD) and kappa opioid receptor (KOR) mRNA in specific brain regions.
• The observed alterations in the kappa/dynorphin system suggest a potential endogenous counter-regulatory mechanism against morphine's central effects.
• These findings contribute to understanding the complex neuroadaptive changes induced by morphine and highlight the involvement of the kappa-opioid system.